{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:31Z","timestamp":1794248611635,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007289","name":"Nanjing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116444","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:50:35Z","timestamp":1784742635000},"page":"116444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apatinib resistance mediated by IRF9 nuclear translocation in head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Yi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116444_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2026.116444_bib2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s12250-021-00413-8","article-title":"Current status of human papillomavirus-related head and neck cancer: from viral genome to patient care","volume":"36","author":"Dong","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.isci.2026.116444_bib3","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.21.01293","article-title":"Weekly cisplatin plus radiation for postoperative head and neck cancer (jcog1008): a multicenter, noninferiority, phase ii\/iii randomized controlled trial","volume":"40","author":"Kiyota","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116444_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40265-023-01835-2","article-title":"Treating head and neck cancer in the age of immunotherapy: a 2023 update","volume":"83","author":"Bhatia","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.isci.2026.116444_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116444_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12916-023-02841-7","article-title":"Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (ahead): a prospective, single-arm, multicenter, phase iv study","volume":"21","author":"Li","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2026.116444_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3350\/cmh.2022.0402","article-title":"Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a chinese perspective","volume":"29","author":"Xie","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.isci.2026.116444_bib8","article-title":"Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116444_bib9","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.7150\/ijbs.83862","article-title":"Integrative analysis of multi-omics data reveals inhibition of rb1 signaling promotes apatinib resistance of hepatocellular carcinoma","volume":"19","author":"He","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2026.116444_bib10","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3389\/fimmu.2018.01831","article-title":"Interferon regulatory factor 9 structure and regulation","volume":"9","author":"Paul","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116444_bib11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","article-title":"The multiple roles of interferon regulatory factor family in health and disease","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116444_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The jak\/stat signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116444_bib13","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The jak-stat pathway at 30: much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116444_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/bfgp\/elt028","article-title":"The il-10\/stat3-mediated anti-inflammatory response: recent developments and future challenges","volume":"12","author":"Hutchins","year":"2013","journal-title":"Brief. Funct. Genomics"},{"key":"10.1016\/j.isci.2026.116444_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117382","article-title":"Research progress of stat3-based dual inhibitors for cancer therapy","volume":"91","author":"Yang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.isci.2026.116444_bib16","doi-asserted-by":"crossref","first-page":"15487","DOI":"10.1021\/acs.jmedchem.2c01554","article-title":"Discovery of a highly potent and orally bioavailable stat3 dual phosphorylation inhibitor for pancreatic cancer treatment","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.116444_bib17","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/s41467-022-33080-8","article-title":"A pilot study of neoadjuvant combination of anti-pd-1 camrelizumab and vegfr2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma","volume":"13","author":"Ju","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116444_bib18","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1200\/JCO.22.01450","article-title":"Camrelizumab plus apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma: an open-label, single-arm, phase ii study","volume":"41","author":"Ding","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116444_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10456-020-09716-y","article-title":"Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself","volume":"23","author":"Yang","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.isci.2026.116444_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10753-023-01896-1","article-title":"Suppression of irf9 promotes osteoclast differentiation by decreased ferroptosis via stat3 activation","volume":"47","author":"Lan","year":"2024","journal-title":"Inflammation"},{"key":"10.1016\/j.isci.2026.116444_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/cancers13020208","article-title":"Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican","volume":"13","author":"Brunn","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.116444_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/cancers14040919","article-title":"The transcription factor irf9 promotes colorectal cancer via modulating the il-6\/stat3 signaling axis","volume":"14","author":"Sharma","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.116444_bib23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/genes15070959","article-title":"The role of irf9 upregulation in modulating sensitivity to olaparib and platinum-based chemotherapies in breast cancer","volume":"15","author":"Choi","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.isci.2026.116444_bib24","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3390\/ijms20051194","article-title":"Nuclear erk: mechanism of translocation, substrates, and role in cancer","volume":"20","author":"Maik-Rachline","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116444_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-023-01649-4","article-title":"Nuclear transport proteins: structure, function, and disease relevance","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116444_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4255\/mcpharmacol.09.19","article-title":"Rangtpase: a key regulator of nucleocytoplasmic trafficking","volume":"1","author":"Lui","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.isci.2026.116444_bib27","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting ran-mediated pparalpha nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116444_bib28","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.3389\/fimmu.2018.02847","article-title":"Sonic hedgehog signaling pathway mediates proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via mapk\/erk signaling pathway","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.116444_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13062-023-00439-w","article-title":"Rcc2 promotes prostate cancer cell proliferation and migration through hh\/gli1 signaling pathway and cancer stem-like cells","volume":"18","author":"Wang","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.isci.2026.116444_bib30","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/exd.14815","article-title":"The shh-gli1 pathway is required in skin expansion and angiogenesis","volume":"32","author":"Zhang","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.isci.2026.116444_bib31","first-page":"13","article-title":"Fzd8 indicates a poor prognosis and promotes gastric cancer invasion and metastasis via b-catenin signaling pathway","volume":"50","author":"Chen","year":"2020","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.isci.2026.116444_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216596","article-title":"Dihydroartemisinin inhibits the development of colorectal cancer by gsk-3beta\/tcf7\/mmp9 pathway and synergies with capecitabine","volume":"582","author":"Dai","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.116444_bib33","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/s41374-019-0277-y","article-title":"Ascl1-induced wnt11 regulates neuroendocrine differentiation, cell proliferation, and e-cadherin expression in small-cell lung cancer and wnt11 regulates small-cell lung cancer biology","volume":"99","author":"Tenjin","year":"2019","journal-title":"Lab. Invest."},{"key":"10.1016\/j.isci.2026.116444_bib34","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s11010-021-04174-6","article-title":"Wnt\/beta-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities","volume":"476","author":"El","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.isci.2026.116444_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.2020006075","article-title":"Jak\/stat pathway inhibition sensitizes cd8 t cells to dexamethasone-induced apoptosis in hyperinflammation","volume":"136","author":"Meyer","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.116444_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12935-021-02304-0","article-title":"Ythdc1-mediated vps25 regulates cell cycle by targeting jak-stat signaling in human glioma cells","volume":"21","author":"Zhu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.isci.2026.116444_bib37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/CJI.0b013e3181ad4092","article-title":"Irf9 is a key factor for eliciting the antiproliferative activity of ifn-alpha","volume":"32","author":"Tsuno","year":"2009","journal-title":"J. Immunother."},{"key":"10.1016\/j.isci.2026.116444_bib38","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/0008-5472.CAN-16-2529","article-title":"Microrna-194 promotes prostate cancer metastasis by inhibiting socs2","volume":"77","author":"Das","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116444_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.chembiol.2023.10.023","article-title":"Pim1 targeted degradation prevents the emergence of chemoresistance in prostate cancer","volume":"31","author":"Torres-Ayuso","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2026.116444_bib40","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13577-019-00295-9","article-title":"Ccnd1 silencing suppresses liver cancer stem cell differentiation through inhibiting autophagy","volume":"33","author":"Zhang","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.isci.2026.116444_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116444_bib42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.fsi.2017.08.046","article-title":"Molecular characterization and expression analysis of interferon-gamma in black seabream acanthopagrus schlegelii","volume":"70","author":"Xiang","year":"2017","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.isci.2026.116444_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41392-024-01934-w","article-title":"The jak-stat pathway: from structural biology to cytokine engineering","volume":"9","author":"Lv","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.116444_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113905","article-title":"A comprehensive study of the metabolism of flavonoid oroxin b in vivo and in vitro by uhplc-q-tof-ms\/ms","volume":"197","author":"Feng","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.isci.2026.116444_bib45","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.3390\/molecules24234384","article-title":"Oroxin b induces apoptosis by down-regulating microrna-221 resulting in the inactivation of the pten\/pi3k\/akt pathway in liver cancer","volume":"24","author":"Li","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.116444_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41592-024-02553-7","article-title":"A peptide-centric local stability assay enables proteome-scale identification of the protein targets and binding regions of diverse ligands","volume":"22","author":"Li","year":"2025","journal-title":"Nat. Methods"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226018195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:02:43Z","timestamp":1794247363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226018195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226018195"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116444","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apatinib resistance mediated by IRF9 nuclear translocation in head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116444"}}